Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis


A variety of commercial analogs and a newer series of Sulindac derivatives were screened for inhibition of M. tuberculosis (Mtb) in vitro and specifically as inhibitors of the essential mycobacterial tubulin homolog, FtsZ. Due to the ease of preparing diverse analogs and a favorable in vivo pharmacokinetic and toxicity profile of a representative analog… (More)
DOI: 10.1371/journal.pone.0164100


17 Figures and Tables